These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 34368764)

  • 1.
    Chariou PL; Beiss V; Ma Y; Steinmetz NF
    Mater Adv; 2021 Mar; 2(5):1644-1656. PubMed ID: 34368764
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inactivated Cowpea Mosaic Virus for In Situ Vaccination: Differential Efficacy of Formalin vs UV-Inactivated Formulations.
    Jung E; Mao C; Bhatia M; Koellhoffer EC; Fiering SN; Steinmetz NF
    Mol Pharm; 2023 Jan; 20(1):500-507. PubMed ID: 36399598
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inactivated Cowpea Mosaic Virus in Combination with OX40 Agonist Primes Potent Antitumor Immunity in a Bilateral Melanoma Mouse Model.
    Koellhoffer EC; Mao C; Beiss V; Wang L; Fiering SN; Boone CE; Steinmetz NF
    Mol Pharm; 2022 Feb; 19(2):592-601. PubMed ID: 34978197
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cowpea Mosaic Virus Outperforms Other Members of the Secoviridae as In Situ Vaccine for Cancer Immunotherapy.
    Beiss V; Mao C; Fiering SN; Steinmetz NF
    Mol Pharm; 2022 May; 19(5):1573-1585. PubMed ID: 35333531
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In Vivo Fate of Cowpea Mosaic Virus In Situ Vaccine: Biodistribution and Clearance.
    Affonso de Oliveira JF; Chan SK; Omole AO; Agrawal V; Steinmetz NF
    ACS Nano; 2022 Nov; 16(11):18315-18328. PubMed ID: 36264973
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cowpea Mosaic Virus Nanoparticles and Empty Virus-Like Particles Show Distinct but Overlapping Immunostimulatory Properties.
    Wang C; Beiss V; Steinmetz NF
    J Virol; 2019 Nov; 93(21):. PubMed ID: 31375592
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antibody Response against Cowpea Mosaic Viral Nanoparticles Improves
    Shukla S; Wang C; Beiss V; Steinmetz NF
    ACS Nano; 2020 Mar; 14(3):2994-3003. PubMed ID: 32133838
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cowpea mosaic virus stimulates antitumor immunity through recognition by multiple MYD88-dependent toll-like receptors.
    Mao C; Beiss V; Fields J; Steinmetz NF; Fiering S
    Biomaterials; 2021 Aug; 275():120914. PubMed ID: 34126409
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In Situ Vaccination with Cowpea vs Tobacco Mosaic Virus against Melanoma.
    Murray AA; Wang C; Fiering S; Steinmetz NF
    Mol Pharm; 2018 Sep; 15(9):3700-3716. PubMed ID: 29798673
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Injectable Hydrogel Containing Cowpea Mosaic Virus Nanoparticles Prevents Colon Cancer Growth.
    Nkanga CI; Steinmetz NF
    ACS Biomater Sci Eng; 2022 Jun; 8(6):2518-2525. PubMed ID: 35522951
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Potency of Cowpea Mosaic Virus Particles for Cancer In Situ Vaccination Is Unaffected by the Specific Encapsidated Viral RNA.
    Jung E; Chung YH; Mao C; Fiering SN; Steinmetz NF
    Mol Pharm; 2023 Jul; 20(7):3589-3597. PubMed ID: 37294891
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plant Viral Nanoparticle Conjugated with Anti-PD-1 Peptide for Ovarian Cancer Immunotherapy.
    Gautam A; Beiss V; Wang C; Wang L; Steinmetz NF
    Int J Mol Sci; 2021 Sep; 22(18):. PubMed ID: 34575893
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plant Virus-Like Particle In Situ Vaccine for Intracranial Glioma Immunotherapy.
    Kerstetter-Fogle A; Shukla S; Wang C; Beiss V; Harris PLR; Sloan AE; Steinmetz NF
    Cancers (Basel); 2019 Apr; 11(4):. PubMed ID: 30974896
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chemical addressability of ultraviolet-inactivated viral nanoparticles (VNPs).
    Rae C; Koudelka KJ; Destito G; Estrada MN; Gonzalez MJ; Manchester M
    PLoS One; 2008 Oct; 3(10):e3315. PubMed ID: 18830402
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The unique potency of Cowpea mosaic virus (CPMV)
    Shukla S; Wang C; Beiss V; Cai H; Washington T; Murray AA; Gong X; Zhao Z; Masarapu H; Zlotnick A; Fiering S; Steinmetz NF
    Biomater Sci; 2020 Sep; 8(19):5489-5503. PubMed ID: 32914796
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In situ vaccination with cowpea mosaic virus elicits systemic antitumor immunity and potentiates immune checkpoint blockade.
    Mao C; Beiss V; Ho GW; Fields J; Steinmetz NF; Fiering S
    J Immunother Cancer; 2022 Dec; 10(12):. PubMed ID: 36460333
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Slow-Release Formulation of Cowpea Mosaic Virus for In Situ Vaccine Delivery to Treat Ovarian Cancer.
    Czapar AE; Tiu BDB; Veliz FA; Pokorski JK; Steinmetz NF
    Adv Sci (Weinh); 2018 May; 5(5):1700991. PubMed ID: 29876220
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Active Microneedle Administration of Plant Virus Nanoparticles for Cancer
    Boone CE; Wang C; Lopez-Ramirez MA; Beiss V; Shukla S; Chariou PL; Kupor D; Rueda R; Wang J; Steinmetz NF
    ACS Appl Nano Mater; 2020 Aug; 3(8):8037-8051. PubMed ID: 33969278
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cowpea Mosaic Virus and Natural Killer Cell Agonism for In Situ Cancer Vaccination.
    Koellhoffer EC; Steinmetz NF
    Nano Lett; 2022 Jul; 22(13):5348-5356. PubMed ID: 35713326
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TLR Agonists Delivered by Plant Virus and Bacteriophage Nanoparticles for Cancer Immunotherapy.
    Jung E; Chung YH; Steinmetz NF
    Bioconjug Chem; 2023 Sep; 34(9):1596-1605. PubMed ID: 37611278
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.